By
Latest Stories
Don’t miss our hot and upcoming stories
PostEra and Amgen Forge AI Drug Discovery Partnership Worth Over $1 Billion
Boston – Nov 16, 2023 Advancing Small Molecule Therapeutics with AI PostEra has entered into…
NVIDIA Backs Terray Therapeutics to Advance Generative AI for Small Molecule Drug Discovery
Los Angeles – Nov 9, 2023 Terray Therapeutics, a biotechnology company pioneering AI-driven small molecule…
Merck (HQ Germany) Strengthens AI-Driven Drug Discovery with Strategic Partnerships with BenevolentAI and Exscientia
Darmstadt, Germany – Sept 20, 2023 Advancing AI-Powered Drug Development in Oncology, Neurology, and Immunology…
BenevolentAI Announces Strategic Collaboration with Merck, Darmstadt, Germany
London, UK – Sept 20, 2023 Partnership Utilizes AI-Driven Drug Discovery to Advance Oncology, Neurology,…